Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
The Journal of Peptide Research : Official Journal of the American Peptide Society|September 13, 2003
Design of peptide mimetics of HIV-1 gp120 for prevention and therapy of HIV diseaseN Veljkovic, D R Branch, R Metlas, et al.
The Journal of Biological Chemistry|October 24, 2000
The SH2 domain containing tyrosine phosphatase-1 down-regulates activation of Lyn and Lyn-induced tyrosine phosphorylation of the CD19 receptor in B cellsA K Somani, K Yuen, F Xu, et al.
Nucleic Acids Research|December 13, 2006
Use of modified U1 snRNAs to inhibit HIV-1 replicationR Sajic, K Lee, K Asai, et al.
AIDS (London, England)|September 1, 1996
HIV infection in vitro enhances the activity of src-family protein tyrosine kinasesD J Phipps, S E Read, J P Piovesan, et al.
Blood|April 1, 1991
Amplification by the polymerase chain reaction of hypervariable regions of the human genome for evaluation of chimerism after bone marrow transplantationL Ugozzoli, P Yam, L D Petz, et al.
Transfusion|September 1, 1993
Transfusion-associated graft-versus-host disease in immunocompetent patients: report of a fatal case associated with transfusion of blood from a second-degree relative, and a survey of predisposing factorsL D Petz, L Calhoun, P Yam, et al.
Biochimica Et Biophysica Acta|November 21, 2007
The medium is the message: glycosphingolipids and their soluble analoguesM De Rosa, H-J Park, M Mylvaganum, et al.
Clinical and Experimental Immunology|June 1, 1995
An octapeptide analogue of HIV gp120 modulates protein tyrosine kinase activity in activated peripheral blood T lymphocytesD J Phipps, P Reed-Doob, D K MacFadden, et al.
Transfusion|September 1, 1992
Selection of platelets for refractory patients by HLA matching and prospective crossmatchingG Moroff, G Garratty, J M Heal, et al.
Transfusion|January 3, 2001
Selecting donors of platelets for refractory patients on the basis of HLA antibody specificityL D Petz, G Garratty, L Calhoun, et al.
Pageof 9